Latest Breaking News On - Hyfinity investments - Page 1 : comparemela.com

Elpiscience Announces CDE IND Clearance of ES014, a First in Class Anti-CD39xTGF-β Bispecific Antibody for Patients with Advanced Solid Tumors

Elpiscience Announces CDE IND Clearance of ES014, a First in Class Anti-CD39xTGF-β Bispecific Antibody for Patients with Advanced Solid Tumors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Hongtao luSteve chinElpiscience biopharmaceuticals incGreater bay area homeland development fundWall streetDrug evaluationInvestigational new drug applicationChief scientific officerChief medical officerBispecific macrophage engagerScientific advisory boardLilly asia venturesHyfinity investmentsCormorant asset

Money on the Move: SwanBio, Remix, Locus, Mirvie and More

Recent funding saw support for a platform that selectively degrades DNA, software to help read mammograms and a company using corn genetics to develop cancer-targeting viruses.

United statesUnited kingdomAspen neuroscienceclosedHarry stinePacira biosciencesDerek strumPeter smithStephen russellJuergen hornAllyson felixDominik schumacherSoutheast minnesota capital fundOxford science enterprisesJjdc incAtlas ventureB future health fund

InxMed Raised $15 million in Series B+ Financing to Advance Innovative Therapies to Drug-resistant Cancers

NANJING, China, May 8, 2022 /PRNewswire/ InxMed Co., Ltd, a clinical-stage biotechnology company dedicated to developing innovative therapies t.

United statesZaiqi wangInxmed nanjing translational medicine centerChina national medical products administrationPrnewswire inxmed co ltdDrug administrationMed nanjing translational medicine centerAnnual meetingAmerican societyClinical oncologyChief executive officerHyfinity investmentsBoehringer ingelheim about hyfinity

Cargene Biopharma Raises US$19 2M in Pre-A Funding Round

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

United statesRoger fooKausik rayTorsten wuestefeldHarvey lodishCargene biopharmaAgency for scienceGenome instituteBiotrack capitalHyfinity investmentsYann chong tan

Cargene Closes a US$19 2M Pre-A Round Led by BioTrack Capital

/PRNewswire/ Cargene Biopharma Inc. ("Cargene") announced today the close of an over-subscribed US$19.2 million pre-Series A funding round. The financing.

United statesKausik rayQinggang zhuangRoger fooTorsten wuestefeldHarvey lodishGenome institute of singaporeAgency for scienceSingapore agency for scienceTechnology organisationPrnewswire cargene biopharma incBiotrack capitalHyfinity investmentsLegendstar capitalYann chong tanProfessors harvey lodish